Science 37 Holdings, Inc.

Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through their Metasite™ they reach an expanded population beyond the traditional site, delivering on their goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of…More their own homes, at their local community provider, or at a traditional site when needed. Their Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data.